Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells.

about

MicroRNA-128 suppresses paclitaxel-resistant lung cancer by inhibiting MUC1-C and BMI-1 in cancer stem cells.

P2860

Q47202039-3D14A176-4E49-4BA3-BE63-3A192986A0DB

P2860

Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells.

Item

http://www.wikidata.org/entity/Q41571715

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Gefitinib-loaded DSPE-PEG2000 ...... target lung cancer stem cells.

@en

type

Item

label

Gefitinib-loaded DSPE-PEG2000 ...... target lung cancer stem cells.

@en

prefLabel

Gefitinib-loaded DSPE-PEG2000 ...... target lung cancer stem cells.

@en

P1476

Gefitinib-loaded DSPE-PEG2000 ...... target lung cancer stem cells.

@en

P2093

Dewen Leng

http://www.w3.org/2001/XMLSchema#string

Jin Sun

http://www.w3.org/2001/XMLSchema#string

Jingsong Huang

http://www.w3.org/2001/XMLSchema#string

Jun Hu

http://www.w3.org/2001/XMLSchema#string

Qi Yao

http://www.w3.org/2001/XMLSchema#string

Shuo Yang

http://www.w3.org/2001/XMLSchema#string

Xiaolong Huang

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Eyes wide open: a critical review of sphere-formation as an assay for stem cells

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

Lung cancer stem cells-characteristics, phenotype

Lung cancer stem cells: progress and prospects

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Progression and metastasis of lung cancer

Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system

Identification and expansion of the tumorigenic lung cancer stem cell population

P2888

s12957-017-1230-4

P304

167

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12957-017-1230-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091371193

http://www.w3.org/2001/XMLSchema#string

P698

28854941

http://www.w3.org/2001/XMLSchema#string

P932

5577827

http://www.w3.org/2001/XMLSchema#string

Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells.

about

P2860

P2860

Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932